MedPath

ong term lung problem of children who were affected by corona virus.

Not Applicable
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Registration Number
CTRI/2020/11/029026
Lead Sponsor
FLUID RESEARCH GRANT
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.All children between age group 4 â?? 15 years with COVID 19 positive getting admitted in CMC will be eligible to participate in the study.

Exclusion Criteria

unwillingness to participate

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.To assess the respiratory sequelae of COVID 19 infection in children, by clinical examination and laboratory investigations during 1 year follow up period.Timepoint: 2 years
Secondary Outcome Measures
NameTimeMethod
1.To find the proportion of children who develop restrictive/ obstructive lung disease following COVID 19 viral infection <br/ ><br>2.To correlate the severity of the respiratory involvement during the acute infection with the long term respiratory status <br/ ><br>3.To study the risk factors for development of respiratory sequelae like restrictive lung disease.Timepoint: 2 years
© Copyright 2025. All Rights Reserved by MedPath